New AMA Report Highlights Lack of Competition in PBM Market - MedCity News
Pharmacy Benefit Managers (PBMs) demonstrate a lack of competition and high vertical integration, impacting drug pricing and accessibility for patients.
Is $20 a Fair Valuation for Oscar Health (OSCR) - or a Stretch Too Far?
Oscar Health's stock surged in June 2025 due to strong earnings, but a subsequent crash raised doubts about its recovery amidst regulatory and market challenges.